E
Evalve
Engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves
About Evalve
Evalve, Inc., founded in 1999, specializes in the design, development, manufacture, and marketing of devices for percutaneous cardiac valve repair. The company's flagship product, the MitraClip® system, focuses on mitral valve repair and aims to minimize the risks, trauma, and costs associated with traditional open-heart surgery. Evalve's MitraClip® system received CE mark approval in 2008, marking it as the world's first percutaneous valve repair system. In October 2009, Evalve was acquired by Abbott Vascular, Inc., expanding its reach and resources. Evalve primarily serves the medical and healthcare markets, targeting hospitals and cardiac care centers. The business model revolves around the sale and distribution of its specialized medical devices, generating revenue through product sales and clinical support services.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1999
- Headquarters
- Menlo Park, United States
- Employees
- 54
- Open positions
- None listed
- Dealroom signal
- 70.1/100
- Industry
- Health, Marketing
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Cardiology and cardiovascular, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Sep 2009 | $410M | $410M | Abbott | — |
| SERIES DOther financing | Nov 2007 | $60M | $240M | Split Rock Partners · Sterling Capital Management · Delphi Ventures · NEA | — |
Growth signals
Latest recorded traffic for Evalve is 0 monthly website visits. Evalve's team declined 10% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later10 investors entered at this stage
Guidant Corporation
Three Arch Partners- SCSt. Paul Venture Capital
Delphi Ventures
NEA
ABS Capital- CCCutlass Capital
Split Rock Partners- SMSterling Capital Management
Abbott
Other known investors2 additional known investors
Columbia University
Stanford University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Evalve on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Evalve’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.